AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2.
Saved in:
| Title: | AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2. |
|---|---|
| Authors: | Subramanian G; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Hage A; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Feldmann F; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Chiramel AI; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., McNally KL; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Sturdevant GL; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Beare PA; Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA., Best SM; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. |
| Source: | Viruses [Viruses] 2024 Aug 29; Vol. 16 (9). Date of Electronic Publication: 2024 Aug 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39339853 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Subramanian+G%22">Subramanian G</searchLink>; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Hage+A%22">Hage A</searchLink>; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Feldmann+F%22">Feldmann F</searchLink>; Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Chiramel+AI%22">Chiramel AI</searchLink>; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22McNally+KL%22">McNally KL</searchLink>; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Sturdevant+GL%22">Sturdevant GL</searchLink>; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Beare+PA%22">Beare PA</searchLink>; Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.<br /><searchLink fieldCode="AU" term="%22Best+SM%22">Best SM</searchLink>; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.; Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101509722%22">Viruses</searchLink> [Viruses] 2024 Aug 29; Vol. 16 (9). <i>Date of Electronic Publication: </i>2024 Aug 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101509722 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1999-4915 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994915%22">19994915 </searchLink><i>NLM ISO Abbreviation: </i>Viruses <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39339853 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/v16091377 Languages: – Code: eng Text: English Titles: – TitleFull: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Subramanian G – PersonEntity: Name: NameFull: Hage A – PersonEntity: Name: NameFull: Feldmann F – PersonEntity: Name: NameFull: Chiramel AI – PersonEntity: Name: NameFull: McNally KL – PersonEntity: Name: NameFull: Sturdevant GL – PersonEntity: Name: NameFull: Beare PA – PersonEntity: Name: NameFull: Best SM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 08 Text: 2024 Aug 29 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1999-4915 Numbering: – Type: volume Value: 16 – Type: issue Value: 9 Titles: – TitleFull: Viruses Type: main |
| ResultId | 1 |